Select Publications
Books
, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.
, 2007, The motor neurone disease handbook, Kiernan MC, (ed.), Australasian Medical Publishing Company, Strawberry Hills, N.S.W.
Book Chapters
, 2024, 'Advances in Brain Imaging', in The Sage Handbook of Cognitive and Systems Neuroscience, SAGE Publications, pp. 533 - 552, http://dx.doi.org/10.4135/9781529616613.n32
, 2023, 'Chemotherapy-Induced Cranial Nerve Damage', in Cranial Nerves in Neurology A Comprehensive and Systematic Evaluation of Cranial Nerves Pathology and Specific Conditions, pp. 189 - 193, http://dx.doi.org/10.1007/978-3-031-43081-7_23
, 2023, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity Second Edition, pp. 1803 - 1821, http://dx.doi.org/10.1007/978-3-031-15080-7_138
, 2023, 'Chapter 14 Amyotrophic lateral sclerosis', in Imaging Neuroinflammation, Elsevier, pp. 363 - 385, http://dx.doi.org/10.1016/b978-0-323-91771-1.00016-2
, 2021, 'Neurotoxicity and ALS: Insights into Pathogenesis', in Handbook of Neurotoxicity, Springer Nature, pp. 1 - 19, http://dx.doi.org/10.1007/978-3-030-71519-9_138-1
, 2020, 'Transcranial magnetic stimulation in the cortical exploration of dementia', in Diagnosis and Management in Dementia the Neuroscience of Dementia Volume 1, pp. 327 - 343, http://dx.doi.org/10.1016/B978-0-12-815854-8.00021-5
, 2020, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Dietz V; Ward NS; Kennard C (ed.), Oxford Textbook of Neurorehabilitation, Oxford University Press (OUP), pp. 253 - 268, http://dx.doi.org/10.1093/med/9780198824954.003.0019
, 2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918
, 2019, 'Motor neuron disease', in Degenerative Disorders of the Brain, Taylor & Francis, pp. 199 - 228, http://dx.doi.org/10.4324/9781351208918-9
, 2016, 'Amyotrophic Lateral Sclerosis', in Neurodegenerative Disorders A Clinical Guide Second Edition, pp. 145 - 165, http://dx.doi.org/10.1007/978-3-319-23309-3_8
, 2015, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Oxford Textbook of Neurorehabilitation, Oxford University Press, USA, pp. 225 - 235
, 2015, 'Neurorehabilitation approaches for disorders of the peripheral nervous system', in Oxford Textbook of Neurorehabilitation, Oxford University Press (OUP), pp. 224 - 237, http://dx.doi.org/10.1093/med/9780199673711.003.0019
, 2014, 'Impulse Conduction: Molecular Perspectives', in Encyclopedia of the Neurological Sciences, pp. 688 - 690, http://dx.doi.org/10.1016/B978-0-12-385157-4.00060-9
, 2014, 'Neurotoxicity and ALS: Insights into pathogenesis', in Handbook of Neurotoxicity, pp. 1435 - 1456, http://dx.doi.org/10.1007/978-1-4614-5836-4_138
, 2013, 'Nerve Conduction Studies', in Encyclopedia of Pain, Springer Nature, pp. 2024 - 2024, http://dx.doi.org/10.1007/978-3-642-28753-4_101376
, 2012, 'Chapter 15 Nerve Excitability A Clinical Translation', in Aminoff's Electrodiagnosis in Clinical Neurology, Elsevier, pp. 345 - 365, http://dx.doi.org/10.1016/b978-1-4557-0308-1.00015-7
, 2011, 'Spinal Muscular Atrophy', in Encyclopedia of Life Sciences (eLS), John Wiley & Sons, Ltd., Chichester, pp. 1 - 7, http://dx.doi.org/10.1002/9780470015902.a0006011.pub2
, 2010, 'Biophysical Properties Underlying Human Nerve Impulse Conduction', in DuBois ML (ed.), Action Potential: Biophysical and Cellular Context, Initiation, Phases and Propagation, Nova Science Publishers, USA, pp. 29 - 63, https://www.novapublishers.com/catalog/product_info.php?cPath=23_483&products_id=14126&osCsid=36c853df640479f435610c963513f08b
, 2010, 'Chemotherapy-induced neurotoxicity', in Hayat MA (ed.), Methods of Cancer Diagnosis, Therapy and Prognosis. Volume 7, Springer, USA, pp. 99 - 119, http://www.springer.com/biomed/cancer/book/978-90-481-3185-3
, 2007, 'Diagnosis of motor nerone disease', in Kiernan M (ed.), The motor neurone disease handbook, Australasian Medical Publishing Company, Strawberry Hills, N.S.W., pp. 89 - 104
, 2007, 'Oxaliplatin-induced neurotoxicity: New pathophysiological insights', in Webster LR (ed.), Neurotoxicity Syndromes, Nova Science Publications, New York, USA, pp. 169 - 181
, 2006, 'Assessment of nerve excitability properties in peripheral nerve disease', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 381 - 403
, 2006, 'Developments in the assessment of peripheral nerve function', in Handbook of Clinical Neurophysiology, Volume 7: Peripheral Nerve Diseases, Elsevier, Amsterdam, pp. 927 - 943
, 2005, 'Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy 2 Volume Set with Expert Consult Basic, pp. 113 - 129, http://dx.doi.org/10.1016/B978-0-7216-9491-7.50008-9
, 2005, 'Chapter 5 Nerve Excitability Measures: Biophysical Basis and Use in the Investigation of Peripheral Nerve Disease', in Peripheral Neuropathy, Elsevier, pp. 113 - 129, http://dx.doi.org/10.1016/b978-0-7216-9491-7.50008-9
, 2005, 'Contributing Authors', in Peripheral Neuropathy, Elsevier, pp. v - xv, http://dx.doi.org/10.1016/b978-0-7216-9491-7.50002-8
, 2005, 'Nerve excitability measures: Biophysical basis and use in the investigation of peripheral nerve disease', in Dyck PJ; Thomas PK (ed.), Peripheral Neuropathy, Elsevier Saunders, Unites States, pp. 113 - 129
, 2004, 'Threshold electrotonus and the assessment of nerve excitability in amyotrophic lateral sclerosis', in Eisen A (ed.), Handbook of Clinical Neurophysiology. Volume 4: Clinical Neurophysiology of Motor Neurone Disease, Elsevier BV, The Netherlands, pp. 359 - 366
, 2003, 'Impulse Conduction', in Encyclopedia of the Neurological Sciences Volumes 1 4, pp. V2-V2-642, http://dx.doi.org/10.1016/B0-12-226870-9/02032-3
, 2003, 'Impulse conduction', in Encyclopedia of the Neurological Sciences, Volume 2, Academic Press, San Diego, pp. 639 - 642
, 1997, 'Excitability of cutaneous sensory axons in amyotrophic lateralis sclerosis', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 145 - 154
, 1997, 'Susceptibility to conduction block: differences in the biophysical properties of cutaneous afferents and motor axons', in Physiology of ALS and Related Diseases, Elsevier, Amsterdam, pp. 43 - 53
Journal articles
, 2027, 'Diaphragm reserve utilisation in motor neurone disease: A novel ultrasound-derived physiological index', Respiratory Physiology and Neurobiology, 347, http://dx.doi.org/10.1016/j.resp.2026.104667
, 2026, 'Neurodegeneration as an evolutionary trade-off: a biological constraint–aware therapeutic perspective', Molecular Neurodegeneration, 21, http://dx.doi.org/10.1186/s13024-026-00958-w
, 2026, 'Multifactorial Contributors to Dose Limiting and Post-Treatment Neurologic Toxicity During Chemotherapy Treatment', Neurology, 107, http://dx.doi.org/10.1212/WNL.0000000000218599
, 2026, 'Corrigendum to “The effects of alterations in conditioning stimulus intensity on short interval intracortical inhibition” [Brain Res. 1273 (2009) 39–47]', Brain Research, 1889, http://dx.doi.org/10.1016/j.brainres.2026.150475
, 2026, 'Astrocytic Lipid Dysregulation in Amyotrophic Lateral Sclerosis', Cellular and Molecular Neurobiology, http://dx.doi.org/10.1007/s10571-026-01840-5
, 2026, 'Cortical changes in amyotrophic lateral sclerosis: comparing biomarkers of glymphatic flow and cortical excitability', Clinical Neurophysiology, 190, http://dx.doi.org/10.1016/j.clinph.2026.2111949
, 2026, 'Current practice of delivering bad news of amyotrophic lateral sclerosis diagnosis in Asian and Oceanian countries: an international survey from a neurologist’s perspective', BMC Neurology, http://dx.doi.org/10.1186/s12883-026-05433-z
, 2026, 'Identity-by-descent to resolve reduced penetrance and advance gene discovery in neurodegenerative disease', Brain, pp. awag326, http://dx.doi.org/10.1093/brain/awag326
, 2026, 'Gold Coast criteria for ALS diagnosis: individual participant data meta-analysis', Journal of Neurology, 273, http://dx.doi.org/10.1007/s00415-026-14046-y
, 2026, 'Muscle Ultrasound Is a Sensitive Outcome Measure in ALS', Muscle and Nerve, 74, pp. 590 - 599, http://dx.doi.org/10.1002/mus.70317
, 2026, 'Systemic dysregulation of apolipoproteins in amyotrophic lateral sclerosis serum', FEBS Open Bio, 16, pp. 1550 - 1562, http://dx.doi.org/10.1002/2211-5463.70232
, 2026, 'The Dynamics of Neurofilament Light Chain in Spinal Muscular Atrophy', Annals of Neurology, 100, pp. 109 - 122, http://dx.doi.org/10.1002/ana.78207
, 2026, 'Measuring Disease Activity During Maintenance Therapy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) (P7-9.003)', Neurology, 106, http://dx.doi.org/10.1212/wnl.0000000000217482
, 2026, 'Application of a Clinical-Electrophysiological Model for Identifying Chronic Inflammatory Demyelinating Polyradiculoneuropathy in an Australian Cohort', Journal of the Peripheral Nervous System, 31, http://dx.doi.org/10.1111/jns.70125
, 2026, 'Strategic Amyotrophic Lateral Sclerosis Australia–Systems Genomics Consortium (SALSA-SGC): cohort profile', BMJ Open, 16, http://dx.doi.org/10.1136/bmjopen-2025-110906
, 2026, 'Utility of Far-Field Potentials as a Biomarker of Neurodegeneration in Spinal Muscular Atrophy', Muscle and Nerve, 73, pp. 1089 - 1095, http://dx.doi.org/10.1002/mus.70231